CH444858A - Verfahren zur Herstellung von Dihydroandrostan-(17,16a-c)-pyridinderivaten - Google Patents
Verfahren zur Herstellung von Dihydroandrostan-(17,16a-c)-pyridinderivatenInfo
- Publication number
- CH444858A CH444858A CH431864A CH431864A CH444858A CH 444858 A CH444858 A CH 444858A CH 431864 A CH431864 A CH 431864A CH 431864 A CH431864 A CH 431864A CH 444858 A CH444858 A CH 444858A
- Authority
- CH
- Switzerland
- Prior art keywords
- dihydroandrostane
- preparation
- pyridine derivatives
- pyridine
- derivatives
- Prior art date
Links
- 150000003222 pyridines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US278442A US3178409A (en) | 1963-05-06 | 1963-05-06 | 1', 4'-dihydroandrostano-[17, 16alpha-c]-pyridines and derivatives thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH444858A true CH444858A (de) | 1967-10-15 |
Family
ID=23064990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH431864A CH444858A (de) | 1963-05-06 | 1964-04-06 | Verfahren zur Herstellung von Dihydroandrostan-(17,16a-c)-pyridinderivaten |
Country Status (5)
| Country | Link |
|---|---|
| CH (1) | CH444858A (de) |
| DE (2) | DE1593656A1 (de) |
| FR (1) | FR1561910A (de) |
| GB (2) | GB1062814A (de) |
| NL (1) | NL6404998A (de) |
-
0
- DE DENDAT1250820D patent/DE1250820B/de active Pending
-
1964
- 1964-03-13 GB GB4103166A patent/GB1062814A/en not_active Expired
- 1964-03-13 GB GB1077464A patent/GB1062813A/en not_active Expired
- 1964-04-02 DE DE19641593656 patent/DE1593656A1/de active Pending
- 1964-04-06 CH CH431864A patent/CH444858A/de unknown
- 1964-05-05 FR FR1561910D patent/FR1561910A/fr not_active Expired
- 1964-05-06 NL NL6404998A patent/NL6404998A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE1250820B (de) | 1967-09-28 |
| FR1561910A (de) | 1969-04-04 |
| NL6404998A (de) | 1964-11-09 |
| GB1062814A (en) | 1967-03-22 |
| DE1593656A1 (de) | 1970-11-26 |
| GB1062813A (en) | 1967-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT271479B (de) | Verfahren zur Herstellung von 2,4-Diamino-5-benzylpyrimidinen | |
| CH449011A (de) | Verfahren zur Herstellung von 2,3-Pyridindiol | |
| CH478813A (de) | Verfahren zur Herstellung von 1,3,5-Triazinderivaten | |
| CH459196A (de) | Verfahren zur Herstellung von 4,6-Pregnadienderivaten | |
| CH437316A (de) | Verfahren zur Herstellung von substituierten Phenyl-amino-1,3-diazacyclopenten-(2)-Verbindungen | |
| AT263750B (de) | Verfahren zur Herstellung von Cyclododecatrien-(1,5,9) | |
| CH458587A (de) | Verfahren zur Herstellung von 8,9,10,11-Tetrahydro-12-phthaloperinon | |
| CH460766A (de) | Verfahren zur Herstellung von 3,3-Alkyliden-19-nor-steroiden | |
| CH479574A (de) | Verfahren zur Herstellung von 13-Jod-14-oxo 13,14-seco-steroiden | |
| AT269377B (de) | Verfahren zur Herstellung von 3-Oxo-13β-alkyl-17β-hydroxy-17α-äthinylgona-5(10), 9(11)-dienen | |
| CH482714A (de) | Verfahren zur Herstellung von substituierten 1,3,4-Oxathiazol-2-onen | |
| CH437294A (de) | Verfahren zur Herstellung von Hexahydro-1-aryl-3-imino-3H-oxazolo-(3,4-a) pyridinen | |
| CH444154A (de) | Verfahren zur Herstellung von 1(10),2,4a(5)-A-Homoöstratrien-4-onderivaten | |
| CH453353A (de) | Verfahren zur Herstellung von 3B-Oxy- 1(10),5-19-nor-steroiden der Androstanreihe | |
| AT247848B (de) | Verfahren zur Herstellung von 1, 3-Dioxo-2-alkylcyclopentanen | |
| CH441583A (de) | Verfahren zur Herstellung von 1,4-Diarylamino-5-nitro-8-hydroxy-anthrachinonen | |
| CH439328A (de) | Verfahren zur Herstellung von 3,5-Dijodthyroninen | |
| CH480354A (de) | Verfahren zur Herstellung von substituierten 1,3-Oxathiol-2-onen | |
| CH471795A (de) | Verfahren zur Herstellung von Derivaten des 1,2-Malonyl-1,2-dihydrocinnolins | |
| CH472395A (de) | Verfahren zur Herstellung von 5,(10),7-Dehydrosteroiden | |
| CH471855A (de) | Verfahren zur Herstellung von 1,2-Dihydroxy-anthrachinonderivaten | |
| AT260894B (de) | Verfahren zur Herstellung von 1,4-Dicyanbuten-(2) | |
| AT253703B (de) | Verfahren zur Herstellung von 3, 6-Dioxo-A-nor-B-homo-steroiden | |
| CH471056A (de) | Verfahren zur Herstellung von 2,5-Dialkoxybenzaldehyden | |
| CH464174A (de) | Verfahren zur Herstellung von 2,6-Dichlor-4-nitrobenzamid |